GM23709
LCL from B-Lymphocyte
Description:
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1
ANDROGEN RECEPTOR; AR
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
LCL from B-Lymphocyte
|
|
Race
|
White
|
|
Ethnicity
|
Not Hispanic/Latino
|
|
Ethnicity
|
GERMAN
|
|
Country of Origin
|
USA
|
|
Family History
|
Y
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
| |
| Gene |
AR |
| Chromosomal Location |
Xq11-q12 |
| Allelic Variant 1 |
313700.0014; SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED |
| Identified Mutation |
(CAG)n EXPANSION; Studying 35 unrelated patients, La Spada et al. (1991) found an increased size of a polymorphic tandem CAG repeat (polyglutamine tract) in the coding region of the androgen receptor gene. These amplified repeats were found in none of 75 controls and segregated with the disease in 15 families. The association was not likely to be due to linkage disequilibrium because 11 different disease alleles were observed.
|
| Remarks |
Clinically affected; onset of symptoms at age 45; this subject has 51 CAG trinucleotide repeats in the first exon of the androgen receptor gene (AR)(normal range= 4-33 copies); positive family history: maternal grandfather had severe leg weakness and 3 male cousins have tested positive for SBMA (samples from family are not in repository). |
| Split Ratio |
1:2 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not Inactivated |
| Substrate |
None specified |
| Subcultivation Method |
dilution - add fresh medium |
| Supplement |
- |
|
|